(Q33809587)

29 July 2017

1 reference

title

Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection (English)

1 reference

29 July 2017

1 reference

1 reference

2

Cacoub P

1 reference

29 July 2017

Lunel F

1

1 reference

PubMed ID

10622590

29 July 2017

language of work or name

1 reference

1 January 1999

1 reference

29 July 2017

Journal of Hepatology

1 reference

29 July 2017

31 Suppl 1

1 reference

29 July 2017

210-216

1 reference

Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Hepatitis C virus and autoimmunity: fortuitous association or reality?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Extrahepatic immunologic features of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Liver/kidney microsome antibody type 1 and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Non-organ specific autoantibodies associated with chronic C virus hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Interferon-induced chronic active hepatitis?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Induction of autoimmune phenomena in patients with chronic hepatitis B treated with gamma-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Autoimmune chronic hepatitis exacerbated by alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Immunological abnormalities and hepatotropic viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

The significance of anti-hepatitis C virus antibodies measured in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Autoimmune chronic active hepatitis: changing reactivity for antibodies to hepatitis C virus after immunosuppressive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Autoimmune chronic hepatitis type 2 manifested during interferon therapy in children

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

A role for hepatitis C virus infection in type II cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Hepatitis C virus infection and type II cryoglobulinemia: an immunological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Treatment of idiopathic mixed cryoglobulinemia with alpha interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Lichen planus and virus C hepatitis: disappearance of the lichen under interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Sudden onset of oral ulcerative lichen in a patient with chronic hepatitis C on treatment with alfa-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980404-8

7 January 2021

10.1016/S0168-8278(99)80404-8

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10622590